Does switching programs change the underlying biology
Carnitine transporter mutations in Crohn's disease consists of missense mutation(s) in the gene coding plasma membrane transporter OCTN1 (SLC22A4) and/or mutation(s) in the promoter of the gene encoding OCTN2 (SLC22A5) [14, 35]
(Nicole Lin), T.E., C.L., R.D., N.L
When conjugated with the p32-binding LyP-1 peptide (CGQKRTRGC), Abraxane, a nanoparticle albumin-bound paclitaxel, accumulated in tumor tissues and inhibited tumor growth more efficiently than untargeted Abraxane 19,20
2024;116(4):e2336
The benzyl alcohol preservative inhibits microbial growth, allowing safe repeated access to the same vial over extended research protocols